Results 241 to 250 of about 39,340 (291)

Cost-effectiveness analysis of disitamab vedotin plus toripalimab versus chemotherapy as treatment for HER2-expressing advanced urothelial cancer in China. [PDF]

BMJ Open
Jia Y, Zhu L, Kang S, Wang X.
europepmc   +1 more source

Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands. [PDF]

Infect Dis Ther
Simons JJM, Zeevat F, Westra TA, Wilschut JC, van Sorge NM, Boersma C, Postma MJ.   +6 more
europepmc   +1 more source

Using QALYs to Allocate Resources: A Critique of Some Objections

, 1994
McTurk, Lesley
core  

Cost-effectiveness of luseogliflozin for the management of type 2 diabetes mellitus in Vietnam: a Markov model analysis from the Vietnam social health insurance perspective. [PDF]

Cost Eff Resour Alloc
Ong TD, Dao AS, Ly QT, Kieu TTM, Le HM.
europepmc   +1 more source

Economic value of ribociclib in early breast cancer in the United States. [PDF]

J Manag Care Spec Pharm
Brufsky A, Tolaney SM, Gadi VK, Chai X, Yang F, Chen W, Ma W, Zhou ZY, Ganapathy V, Patel A, Sopher G, Alexander E, Bollu V, Garrison LP, Sparano JA.   +14 more
europepmc   +1 more source

ABSTRACTS

Precision Radiation Oncology, EarlyView.
wiley   +1 more source

Measuring the health benefits and costs of antimicrobial-resistant gonorrhea surveillance in the United States: an agent-based model and cost-effectiveness analysis. [PDF]

Lancet Reg Health Am
Ekanayake-Weber MS, Rönn MM, Yin X, Hsu K, Li Y, Gift TL, Chesson H, Frankson R, Salomon JA, Grad YH, Yaesoubi R.   +10 more
europepmc   +1 more source

Cost-effectiveness of organised versus opportunistic mammography breast cancer screening in low-resourced country. [PDF]

BMJ Open
Al Rabayah A, Mandrik O, Mansour A, Al-Ajlouni R, Haddad T, Abdel-Razeq H, Shamieh O, Chalkidou K, Sullivan R, Gheorghe A.   +9 more
europepmc   +1 more source